10 lectures · 110 items
17 min
10 min
35 min
15 min
10 min
4 min
8 min
12 min
7 min
9 min
Statement finds cardiovascular benefit with typical coffee intake, harm signal with energy drinks
Study on Cardiovascular Risk Factors and Primary Care Utilization in SpainDiagnosis and management of hypertension in primary care | French abstractDiagnosis and management of hypertension in primary care | Greek abstractDiagnosis and management of hypertension in primary care | Ukrainian abstractDIJAGNOSTIKOVANJE I LEČENJE HIPERTENZIJE U PRIMARNOJ ZDRAVSTVENOJ ZAŠTITI | Serbian abstract of EPCCS Guidance on hypertension
Diagnosis and management of hypertension in primary careEducation, exchange, guidance and interaction during EPCCS Summit 2019
Slides | Recent updates to the International Hypertension guidelines - where do they vary and what should we agree in primary care?Hypertension – can we agree on diagnostic and therapeutic thresholds?
Slides | Hypertension - can we agree on diagnostic and therapeutic thresholds
Slides | Practical workshop on ABPM 
Stimulating health behaviour changes to reduce cardiovascular risk in primary care
Controversies in Hypertension – what are the implication of SPRINT in the context of recent treatment trials?
What's the evidence base for blood pressure modification in the guideline updates?the once-daily GLP-1 pill orforglipron lowers the apnoea-hypopnoea index in moderate to severe sleep apnoea with obesity by 12 to 13 events per hour more than placebo, with 10 percent weight loss and 7 mmHg lower blood pressure
Presented in LBS.05 at AHA 2026 (Monday 9 November) by Vaishnavi Kundel (Mount Sinai) and published simultaneously in JAMA (first author Atul Malhotra). ATTAIN-OSA comprises two 52-week, phase 3…
a systolic target below 120 mmHg after ischaemic stroke or TIA gives 21 percent fewer cardiovascular events than below 140, at the price of more renal function decline
Presented in LBS.02 at AHA 2026 (Saturday 7 November, Gisele Sampaio Silva, Federal University of Sao Paulo) and published simultaneously in NEJM. OPTIMAL-Stroke randomised 4,368 adults (mean age…
a systolic target below 120 mmHg in type 2 diabetes does not significantly lower cardiovascular events (6.0 versus 6.7 percent) and gives more renal function decline
Presented in LBS.03 at AHA 2026 (Saturday 7 November, Karla Santo, Hospital Israelita Albert Einstein, Sao Paulo) and published simultaneously in NEJM. OPTIMAL-DIABETES randomised 9,476 adults aged…
A systematic review and Bayesian network meta-analysis.
A Bayesian network meta-analysis of 284 RCTs (18,750 participants) evaluated ten exercise modalities and optimal dosing for blood pressure reduction in adults with prehypertension or hypertension…
Incidence, 30-Day Case Fatality Rates, and Risk Factors Over Time in a Population-Based Study.
A population-based study spanning nearly 30 years reveals that stroke incidence in young adults (20–54 years) has nearly doubled, rising from 33.9 to 62.2 per 100,000 person-years, driven primarily…
An Important Window of Opportunity to Optimize Maternal Health.
This narrative review highlights the substantial long-term cardiovascular risk associated with hypertensive disorders of pregnancy and positions the postpartum period as a critical window for…
Key Updates, Historical Context, and Clinical Implications.
The 2025 AHA/ACC hypertension guideline maintains the <130/80 mmHg treatment goal but adopts a strictly risk-based approach, recommending pharmacotherapy for stage-1 hypertension once the 10-year…
consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.
The European Society of Hypertension has issued a consensus statement on wearable wristwatch cuff oscillometric blood pressure monitors. A systematic review identified only two devices (Omron…
A systematic review and meta-analysis.
A meta-analysis of 32 RCTs (47,332 participants) compared the blood pressure-related safety profiles of tirzepatide and semaglutide in patients with type 2 diabetes or obesity. Tirzepatide…
Intensive blood-pressure lowering reduces mortality and cardiovascular disease in clinical trials, but real-world BP measurements often differ from standardised protocols. In this retrospective…
Intensive blood-pressure lowering reduces mortality and cardiovascular disease in clinical trials, but real-world BP measurements often differ from standardised protocols. In this retrospective…
an individual-participant data meta-analysis.
This individual-participant-data meta-analysis from the Blood Pressure Lowering Treatment Trialists' Collaboration (46 trials, 285,124 participants) examined blood-pressure lowering across all stages…